Selective advantage: The Court of Justice of the European Union confirms a judgment whereby the General Court dismissed the action of the Belgian State against the decision of the Commission declaring partly compatible and partly incompatible with the internal market the funding of tests of bovine spongiform encephalopathy (Belgium / Commission)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. From 1 January 2001 to 31 December 2005, the Belgian authorities participated in the financing of tests for bovine spongiform encephalopathy (BSE), made compulsory by Regulation No 999/2001 of 29 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (OJ 2001 L 147, p. 1). Background After receiving a complaint and initiating a formal investigation procedure, the Commission, by Decision 2011/678/EU of 29 June 2011 (OJEU 2011, L 274, p. 36), that the financing of those tests by the Belgian authorities constituted compatible aid for the period from 1 January 2001 to 31 December 2002 and